Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Fourth Circuit Court Rules Hemp-Derived Products Legal Nationwide, Contradicting DEA":
Sep19, 2024
Remember, Grasser and Dowling get to split over a million bucks if there's a change of control...
"On September 12, 2023, the Arbitrator granted in part and denied in part the motion to dismiss the Company's officers..."
"Post-hearing briefing is expected to conclude on or about November 6, 2024."
https://www.otcmarkets.com/filing/html?id=17756513&guid=xCO-kp38d5wfJth#CVSI-20240630_HTM_notes_to_condensed_financial_statements
"...if there is a change of control, Dowling would get $600k and Grasser would get $470k..."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174808009
"On November 5, 2021, Mona Jr. filed a complaint against the Company for breach of contract and negligence in Nevada state court seeking to recover from the Company the amount of federal and state taxes, interest and penalties owed by Mona Jr. for taxes on income received..."
"On July 6, 2023, the Arbitrator issued an order scheduling the hearing on the merits for April 8 through April 12, 2024. On September 12, 2023, the Arbitrator granted in part and denied in part the motion to dismiss the Company's officers, requiring the case to proceed to a hearing on the merits. The hearing on the merits began on April 8, 2024, and the Arbitrator heard five days of testimony. The hearing resumed on May 21, 2024 and concluded on May 23, 2024. Post-hearing briefing is expected to conclude on or about November 6, 2024. A decision from the Arbitrator is expected to follow. Management believes that Mona Jr.'s claims lack merit. Nevertheless, an unfavorable outcome would have a material impact on the Company's financial condition and results of operations. Management intends to vigorously defend the allegations."
https://www.otcmarkets.com/filing/html?id=17756513&guid=xCO-kp38d5wfJth#CVSI-20240630_HTM_notes_to_condensed_financial_statements
"On March 17, 2015, Michael Ruth filed a shareholder derivative suit..."
"On June 23, 2023, the Company received notice of a court order dated May 23, 2023 without any hearing, granting plaintiff's motion for attorney's fees and expenses of approximately $250,000, which the Company accrued as of June 30, 2024. On or about May 1, 2024, the Company and plaintiff executed a stipulation for the payment of the plaintiff's attorney's fees and expenses over the course of approximately eighteen months subject to a confession of judgment."
https://www.otcmarkets.com/filing/html?id=17756513&guid=xCO-kp38d5wfJth#CVSI-20240630_HTM_notes_to_condensed_financial_statements
"Citing failures to protect public health, lawmaker looks to remove FDA's food authority":
August 2nd 2024
You got it. Here's something from the Gov side...
"Congress Advances Cannabis and Hemp Proposals":
July 29, 2024
https://www.jdsupra.com/legalnews/congress-advances-cannabis-and-hemp-5541083/
Looks like the $900k net from the note is just to cover the annual salaries and bonuses of Dowling and Grasser...Also worth noting is that if there is a change of control, Dowling would get $600k and Grasser would get $470k...
Based on the recent 8-k, the current market cap is about 8 times higher than management's own valuation of the company.
Current market cap is $9.5mil, but management put up ALL assets and then some as collateral for a $1,188,500 loan...
I found a recently published research paper that was funded by Charlotte's Web, and I threw in a couple more papers below it as well. The one funded by Charlotte's Web is focused on a new cannabinoid called Cannabielsoin or CBE, (there is S-CBE and R-CBE, this paper focused on S-CBE), which is an oxidation product of CBD. You guys know I love seeing stuff like this...Enjoy!
"Cannabielsoin (CBE), a CBD Oxidation Product, Is a Biased CB1 Agonist":
Published: 12 July 2024
"Case Report: Cannabis Oil Treats Common Skin Disease in Dog":
JUL 11, 2024
Here's an article that gets into more specifics...
"How the Supreme Court Overturning a Case Against Chevron Oil Threw the Marijuana Industry into Chaos":
Jul 8, 2024
Yeah, there's always that question of when. Maybe the Chevron ruling will combine with rescheduling to make schedule 3 even more meaningful to companies. At the very least, companies soon won't have to remove every molecule of THC to gain FDA approval...
"Cannabis Medications Could Be Eligible For FDA Approval Under Proposed DEA Rules":
July 8, 2024
"Supreme Court’s Chevron Doctrine Ruling Could Limit FDA’s Regulatory Authority":
Jul 01, 2024
FYI-"The FDA’s power to determine a drug’s exclusivity or review tobacco marketing applications faces fresh vulnerability to legal battles after the Supreme Court’s decision to nix a legal doctrine that empowered agency interpretations.
The US Supreme Court’s June 28 opinion in Loper Bright Enters. v. Raimondo is expected to open the floodgates for litigation against the Food and Drug Administration after ending the decades-old Chevron doctrine. Under the 1984 decision in Chevron v. Natural Resources Defense Council, courts had accepted a federal agency’s reasonable interpretation of its rulemaking authority when its statute was determined ambiguous."
https://news.bloomberglaw.com/health-law-and-business/fda-drug-approvals-rulemaking-are-tested-after-chevron-decision
The "Autism" trend chart is even more shocking than the earlier chart for ASD, "Autism Spectrum Disorder"...
Does anyone have any politically correct explanations for this chart?...
"Autism"
https://trends.google.com/trends/explore?date=all&geo=US&q=%2Fg%2F121kwpxw&hl=en-US
That ASD trend chart shocked me. It should be on the news.
"Could an NLRP3 inhibitor be the one drug to conquer common diseases?":
February 17, 2020
https://cen.acs.org/pharmaceuticals/drug-discovery/Could-an-NLRP3-inhibitor-be-the-one-drug-to-conquer-common-diseases/98/i7
CBD's range of powers should make more sense now...
"Pharma Looks to Inflammasome Inhibitors as All-Around Therapies":
Apr 1, 2021
Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.
https://www.the-scientist.com/pharma-looks-to-inflammasome-inhibitors-as-all-around-therapies-68582
"...finding drugs to selectively stop NLRP3 will be difficult."
https://cen.acs.org/pharmaceuticals/drug-discovery/Could-an-NLRP3-inhibitor-be-the-one-drug-to-conquer-common-diseases/98/i7
"...we emphasize the capacity of cannabidiol to suppress inflammation by blocking the NLRP3 signaling pathway..."
https://link.springer.com/article/10.1007/s00011-023-01831-y
Recreate+MLB+PLL website looking good...
https://recreateyou.com/mlb
https://recreateyou.com/pll
"Farmers, businesses push back on Florida Republicans' efforts to restrict THC products"
Feb 16, 2024
https://www.orlandoweekly.com/cannabis/farmers-businesses-push-back-on-florida-republicans-efforts-to-restrict-thc-products-36201768
Same goes for ASD..."Multiple inflammasome complexes are activated in autistic spectrum disorders":
2016 Mar 12
"Inflammasomes"...Looks like we're on to something here...CBD/Hemp extract has shown promise for all of these conditions as well...
"...Inflammasome Activation Is Pathogenic in Multiple Neurological Diseases":
Feb. 14, 2024
Re: Social benefit projects...I was happy with what these guys were doing with Realm of Caring and thought they would do more together. Maybe the FDA would pick on them for it now. I don't know, but I do think CW should do all, most, or at least some of their social benefit work through RoC. It made more sense IMO.
The jabs could use a sprinkle of CBD to tone down the pericarditis a bit...
"Cannabidiol Formulation Granted Orphan Drug Designation for Pericarditis"
February 15, 2024
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173861656
Well, whaddya know. FDA grants orphan drug status for a CBD formulation to protect from a very popular "vaccine" side effect, based on the NLRP3 inflammasome I posted about a couple weeks ago..."Cannabidiol Formulation Granted Orphan Drug Designation for Pericarditis":
February 15, 2024
"Botanical Drug Development Guidance for Industry":
https://www.fda.gov/media/93113/download
Fwiw, I was happy to see the CEO of Ben and Jerry's in the picture at all as I sent the company an email suggesting they work with Ben and Jerry's years ago. I meant something more like a business venture though and not just another board member as I think this company has had way too many execs and board members passing through already. They need permanent long term people who are dedicated to the bigger long term goals. Hopefully, something bigger can come out of them working together. I saw he took no shares when he joined the Board, which is different than usual...
https://www.otcmarkets.com/filing/html?id=17247304&guid=5Qd-kKhdNG6Vvhh
I am aware of the very real effect of full spectrum hemp extract on Autism and I think that should be one of the best and most widespread uses for it. I am still waiting for an autistic spectrum relative's federal legal situation(drug tests) to finish up after many years so they can try it for the first time. I think it could be a life changer for them. My pessimism here comes only from the business side, not the science side at all.
I also am not a fan of corporate America's version of "social equity". "Get woke, go broke" is a well known saying now for a reason. I'd like to see CW drop the B corp designation, donate to an appropriate charity when it makes sense, and stop giving away money, products, and company IP based on sexual preference and skin color. Corporate wokeness is just racism and bigotry and was supposed to be illegal in America. I grew up in a genuinely multicutural way, in one of the most multicultural neighborhoods in America, with friends and girlfriends of all races, so the fake woke shit is just nails on a chalk board to me. Gay people are not victims who deserve free money just because they are gay and it's not ok to give away shareholder IP to farmers just because they are Black farmers and not White or Asian farmers.
I honestly can't believe I've found my self explaining this stuff to adults who run million or billion dollar corporations in 2024, but here we are, that's our country now, a confused cult. I never expected Big Tobacco to be involved here, and am surprised I stuck around after they showed up. However, if they can stick to CW's original mission, I am all for their redemption. This company's social goals were originally supposed to be about disabled children and adults who lacked access to the plant. That is a mission I can respect. Those people really do need the products and support. I wont be lead astray like the kids today though into cheering for a social philosophy that I know is the exact opposite direction of where the country was headed 15-25 years ago, when we were much more on the right track. I want to see the original mission succeed and will criticize deviation from that, especially when it is morally bankrupt and detrimental to shareholders.
New 8-K...not sure why the big drop...
https://www.otcmarkets.com/filing/html?id=17276969&guid=8dd-keHwt05eJth
"Black⬛️Rock and Fidelity Continue to Lead Spot BTC ETF Inflows"...
4 hours ago
https://www.coinspeaker.com/bitcoin-52k-spot-btc-etf-inflows/
You got it MG. Apparently, it is kind of old news, but it's new to me. Venmo customer service was shocked about it when I asked them, as if they had never heard of it before. They said they would email back a response and confirmation of our phone discussion and never got back to me at all...what to do next???...
"Why Venmo sent my personal info – and yours – to Braze":
Feb 24, 2020
https://www.usatoday.com/story/tech/2020/02/24/why-okcupid-venmo-grindr-send-braze-personal-info/4845495002/